Drug Information

Drug General Information
Drug ID
D0P5NW
Former ID
DIB001617
Drug Name
SB-236049
Synonyms
SB-236049; SB-236080; SB-238569; Tricyclic broad-spectrum metallo-beta-lactamase inhibitors, SmithKline Beecham
Drug Type
Small molecular drug
Indication Bacterial infections [ICD9: 001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104; ICD10:A00-B99] Terminated [526339]
Company
SmithKline Beecham Pharmaceuticals
Structure
Download
2D MOL

3D MOL
Formula
C14H9NO6
Canonical SMILES
c12c(c(c(cc2oc2c(c1=O)cnc(c2)C)O)O)C(=O)O
PubChem Compound ID
9860695
Target and Pathway
Target(s) Beta-lactamase Target Info Inhibitor [526339]
References
Ref 526339Identification of a series of tricyclic natural products as potent broad-spectrum inhibitors of metallo-beta-lactamases. Antimicrob Agents Chemother. 2002 Jun;46(6):1880-6.
Ref 526339Identification of a series of tricyclic natural products as potent broad-spectrum inhibitors of metallo-beta-lactamases. Antimicrob Agents Chemother. 2002 Jun;46(6):1880-6.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.